During the past decade, Department of Hepatology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Department of Hepatology" are "Hepatocellular Carcinoma" (1 trials) and "Non-Alcoholic Fatty Liver Disease" (1 trials). Many other conditions were trialed in "Department of Hepatology" in a lesser frequency.

Most popular intervention types in "Department of Hepatology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lenvatinib" (1 trials) and "Obeticholic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Hepatology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Department of Hepatology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Department of Hepatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Hepatology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".